Investing Profile
Greg Yap
Your Intro Paths to Greg Yap
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Greg is a member of
GE Network
21 CONNECTIONS
Menlo Ventures Network
16 CONNECTIONS
The Aspen Institute Network
15 CONNECTIONS
Find Greg Yap on
cbCurrent Investing Position
Menlo Ventures Partner
Investment Range
$8.0M - $15.0M
Sweet Spot
$12.0M
Current Fund Size
$500M
Greg Yap is on these Sector & Stage Rankings
Medical Devices (Seed)BioTech (Series B)Medical Devices (Series B)Medical Devices (Series A)BioTech (Seed)BioTech (Series A)Health IT (Series A)Health & Hospital Services (Series B)Health & Hospital Services (Series A)San Francisco Bay AreaDigital Health (Series B)Health IT (Seed)Health IT (Series B)Digital Health (Series A)Digital Health (Seed)Health & Hospital Services (Seed)
Greg Yap's Experience
Investor Xaira Therapeutics2024 - Present
Board Member & Investor Vilya2023 - Present
Board Member & Investor Cartwheel2023 - Present
Board Member & Investor Koala Health2022 - Present
Investor Scribe Therapeutics2021 - Present
Board Member & Investor Ophelia2021 - Present
Board Member & Investor Particle Health2020 - Present
Board Member & Investor H12020 - Present
Board Observer & Investor Genesis Therapeutics2020 - Present
Health Innovators Fellow The Aspen Institute2019 - Present
Board Member & Investor Clear Labs2019 - Present
Investor Benchling2019 - Present
Investor Encoded Therapeutics Inc.2019 - Present
Board Member & Investor Riva Health2019 - Present
Board Member & Investor Delfi Diagnostics2019 - Present
Board Member & Investor Epiodyne2018 - Present
Investor Pliant Therapeutics2018 - Present
Partner Menlo Ventures2017 - Present
Investor Recursion2017 - Present
Board Member Outward Bound California2013 - Present
Entrepreneur in Residence Illumina Ventures2016 - 2017
CEO & Co-founder PyrAmes2016 - 2017
CEO & Co-founder Biodesy (now BlueLight Therapeutics, Inc.)2013 - 2016
Entrepreneur in Residence GE2013 - 2013
Lifecycle Leader (SVP), Advanced Assays Ventana Medical Systems2010 - 2013
Lifecycle Leader (SVP), Advanced Assays Roche Diagnostics2010 - 2013
Chief Operating Officer CellPoint Diagnostics2008 - 2009
Vice President, Molecular Diagnostics Affymetrix2006 - 2008
Vice President, DNA Products Affymetrix2001 - 2005
Director, Business Development Affymetrix1997 - 1999
Business Analyst McKinsey1995 - 1997
Investors who invest with Greg Yap
Scouts & Angels Affiliated With Greg Yap